With the analysis among 33,035 patents, we discovered top 482 key players by total patent application. Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Novartis AG are dominant in this area. They take 12.51% of the total patent filing.
New York, United States
Patent: 2,068
Basel-Stadt, Switzerland
Patent: 723
Pennsylvania, United States
Patent: 615
New Jersey, United States
Patent: 610
Delaware, United States
Patent: 588
California, United States
Patent: 578
Antwerpen, Belgium
Patent: 539
With the analysis among 626 patents, we discovered top 51 start-ups by total patent application. Shenzhen Tajirui Biomedical Co. Ltd., Cellix Bio Pvt Ltd., SyntheX, Inc. are active in this area.
Guangdong Sheng, China
Patent: 188
Telangana, India
Patent: 89
California, United States
Patent: 58
Shanghai Shi, China
Patent: 54
Jiangsu Sheng, China
Patent: 27
Karnataka, India
Patent: 21
California, United States
Patent: 16
Utah, United States
Patent: 13
With the analysis among related 6,994 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Bristol Myers Squibb Co., FMC Corp., Syngenta Crop Protection AG take 11.94% of patent filing during this period.
New York, United States
Patent: 319
Pennsylvania, United States
Patent: 300
undefined undefined
Patent: 216
Basel-Stadt, Switzerland
Patent: 216
Sichuan Sheng, China
Patent: 124
Colorado, United States
Patent: 108
California, United States
Patent: 108
Guangdong Sheng, China
Patent: 98
With the analysis among related 6,994 patents in last 5 years, we discover 235 new entrants. GenFleet Therapeutics (Shanghai) Co., Ltd., Chengdu Baiyu Pharmaceutical Co., Ltd., Zhejiang Jinfang Pharmaceutical Co Ltd are the most active new entrants in this area.
Shanghai Shi, China
Patent: 54
Sichuan Sheng, China
Patent: 50
Zhejiang Sheng, China
Patent: 50
Guangdong Sheng, China
Patent: 36
Shanghai Shi, China
Patent: 26
Jiangsu Sheng, China
Patent: 25
Shanghai Shi, China
Patent: 24
With the analysis among 2,694 patents, we discovered top 243 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of British Columbia, Chinese Academy of Medical Scciences & Peking Union Medical College are dominant in this area. They take 10.36% of the total patent filing.
Shanghai Shi, China
Patent: 123
British Columbia, Canada
Patent: 74
Massachusetts, United States
Patent: 64
Liaoning Sheng, China
Patent: 51
Jiangsu Sheng, China
Patent: 40
Beijing Shi, China
Patent: 39
Massachusetts, United States
Patent: 36
British Columbia, Canada
Patent: 36